Sleep Disorder Caused by Proctalgia Fugax

2014 ◽  
Vol 11 (2) ◽  
pp. 69-71
Author(s):  
Ki Hoon Kim ◽  
Kyoo Ho Cho ◽  
Yang-Je Cho ◽  
Kyoung Heo
Keyword(s):  
Sleep Disorder ◽  
Proctalgia Fugax

Der akute anale Schmerz

2013 ◽  
Vol 70 (7) ◽  
pp. 399-402
Author(s):  
Olivier Pittet ◽  
Nicolas Demartines ◽  
Dieter Hahnloser
Keyword(s):  
Levator Ani ◽  
Klinische Untersuchung ◽  
Proctalgia Fugax ◽  
Chronische Analfissur ◽  
Levator Ani Syndrome

Anale Schmerzen sind häufig in der Proktologie. Eine detaillierte Anamnese der Schmerzen und die klinische Untersuchung führen meistens zur Diagnose und damit zur unmittelbaren Therapie. Die akute Perianalvenenthrombose soll innerhalb 72 Stunden exzidiert werden. Akute Analfissuren werden konservativ mit Stuhlregulation und sphinktertonus-senkender Medikation sehr erfolgreich therapiert. Die chronische Analfissur muss meistens operiert werden. Perinalabaszesse können häufig in Lokalanästhesie abgedeckelt werden. Die proctalgia fugax und das levator ani syndrome sind Auschlussdiagnosen und werden symptomatisch therapiert.

Sleep Disorder Tied to Impairment, Parkinson's

2012 ◽  
Vol 42 (1) ◽  
pp. 66
Author(s):  
JEFF EVANS
Keyword(s):  
Sleep Disorder

The role of orexin A in pathophysiological mechanisms of sleep disorder in postmenopausal women

GYNECOLOGY ◽  
2020 ◽  
Vol 22 (1) ◽  
pp. 50-54
Author(s):  
Zukhra Kh. Ebzieva ◽  
Svetlana V. Yureneva ◽  
Tatiana Yu. Ivanets
Keyword(s):  
Hormone Therapy ◽  
Sleep Disorder ◽  
Postmenopausal Women ◽  
Menopausal Hormone Therapy ◽  
Reproductive Age ◽  
Vasomotor Symptoms ◽  
Women Of Reproductive Age ◽  
Orexin A ◽  
Group 1

Aim. To conduct a comparative analysis of serum orexin A levels in women of different age periods with and without sleep disorder and vasomotor symptoms. To evaluate the dynamics of orexin A levels under menopausal hormone therapy. Materials and methods. The study included 50 postmenopausal women and 30 women of reproductive age with a regular menstrual cycle. Using block randomization, patients are divided into 3 groups: group 1 (main group), n=25, -STRAW+ 10 (+1b and +1c), patients with sleep disorder and vasomotor symptoms; group 2 (comparison group), n=25, STRAW+ 10 (+1b and +1c), patients with vasomotor symptoms without sleep disorder; group 3 (control group), n=30, STRAW+ 10 (-4), women of reproductive age without sleep disorder. Group 1 patients were given menopausal hormone therapy. A comparative analysis was carried out using the questionnaire for assessing menopausal symptoms severity by the Greene Scale (the Greene Climacteric Scale) and Rating Scale for subjective sleep characteristics. After 12 weeks of treatment, a control examination was performed. Results. In group 1 women, the serum orexin A levels were significantly higher compared to the women without the symptoms. The link between the orexin A levels and menopause syndrome severity was established. A significant decrease in the menopausal symptoms severity after 12 weeks of menopausal hormone therapy was shown. It was accompanied by a 1,3-fold decrease in orexin A levels. Conclusions. The obtained data indicate the possible role of orexin A and the orexin neuropeptide system in the pathogenesis of sleep disorder and vasomotor symptoms in postmenopausal women.

The Stony Brook 600 the Experience of a Sleep Disorder Center

1990 ◽  
Vol 2 (4) ◽  
pp. 277-283 ◽  
Author(s):  
Wallace Mendelson
Keyword(s):  
Sleep Disorder

scholarly journals Relationship between Sleep and Hypertension: Findings from the NHANES (2007–2014)

2021 ◽  
Vol 18 (15) ◽  
pp. 7867
Author(s):  
Chunnan Li ◽  
Shaomei Shang
Keyword(s):  
Blood Pressure ◽  
Sleep Disorder ◽  
Sleep Duration ◽  
Sleep Pattern ◽  
Poor Sleep ◽  
Sleep Patterns ◽  
Short Sleep Duration ◽  
Logistic Regression Models ◽  
Increased Risk ◽  
Definition Of

Background: To evaluate the association of sleep factors (sleep duration, self-reported trouble sleeping, diagnosed sleep disorder) and combined sleep behaviors with the risk of hypertension. Methods: We analyzed 12,166 adults aged 30–79 years who participated in the 2007–2014 National Health and Nutrition Examination Survey. Sleep duration, self-reported trouble sleeping and sleep disorders were collected using a standardized questionnaire. We included three sleep factors (sleep duration, self-reported trouble sleeping and sleep disorder) to generate an overall sleep score, ranging from 0 to 3. We then defined the sleep pattern as “healthy sleep pattern” (overall sleep score = 3), “intermediate sleep pattern” (overall sleep score = 2), and “poor sleep pattern” (0 ≤ overall sleep score ≤ 1) based on the overall sleep score. The definition of hypertension was based on self-reported antihypertensive medication use or biological measurement (systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg). We used weighted logistic regression models to investigate the associations between sleep and hypertension. Results: The overall prevalence of hypertension was 37.8%. A short sleep duration (OR = 1.20, 95% CI: 1.08 to 1.33, p = 0.001), self-reported trouble sleeping (OR = 1.45, 95% CI: 1.28 to 1.65, p < 0.001) and sleep disorder (OR = 1.33, 95% CI: 1.07 to 1.66, p = 0.012) were related to the risk of hypertension. Poor sleep patterns were closely correlated with the risk of hypertension (OR = 1.90, 95% CI: 1.62 to 2.24). Conclusions: Participants with poor sleep patterns were associated with an increased risk for hypertension.

Comorbid Insomnia and Sleep Apnea: mechanisms and implications of an underrecognized and misinterpreted sleep disorder

2021 ◽  
Author(s):  
Miguel Meira e Cruz ◽  
Meir Kryger ◽  
Charles Morin ◽  
Luciana Palombini ◽  
Cristina Salles ◽  
...  
Keyword(s):  
Sleep Apnea ◽  
Sleep Disorder ◽  
Comorbid Insomnia
Sign in / Sign up

Export Citation Format

Share Document